Home/Hedge Fund Intelligence/4D Molecular Therapeutics, Inc.
Nasdaq: FDMTStockForm 13F30 Jun 2026

Hedge funds that hold 4D Molecular Therapeutics, Inc. Nasdaq: FDMT

CUSIP 35104E100 · who reports it, how much, and how much it matters to them

23 of the 720 hedge fund managers we track reported shares of 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT) on Form 13F for 30 June 2026. Between them they reported USD 175m. The largest position belongs to Ra Capital Management, at USD 67m. The manager with the most riding on it is Acuta Capital Partners, where it is 4.7% of the reported book.

Managers reporting it23of 720 we track
Value they reportUSD 175mshares only, 30 Jun 2026
Funds they run338with a file on PPLI.com
Largest positionUSD 67mRa Capital Management
Typical weight0.0%median share of a manager's book
Heaviest weight4.7%Acuta Capital Partners

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

23 managers, USD 175m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports 4D Molecular Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Ra Capital Management1 fund on PPLI.comUSD 67m0.6%
2Adage Capital Management1 fund on PPLI.comUSD 30m0.0%
3Armistice Capital1 fund on PPLI.comUSD 27m0.3%
4Citadel Advisors32 funds on PPLI.comUSD 9.1m0.0%
5Renaissance Technologies13 funds on PPLI.comUSD 8.2m0.0%
6Acuta Capital Partners2 funds on PPLI.comUSD 6.8m4.7%
7RTW Investments2 funds on PPLI.comUSD 6.3m0.1%
8Schonfeld Strategic Advisors30 funds on PPLI.comUSD 5.4m0.0%
9Burkehill Global Management5 funds on PPLI.comUSD 3.7m0.1%
10Arrowmark Colorado Holdings24 funds on PPLI.comUSD 2.7m0.1%
11Brevan Howard Capital Management39 funds on PPLI.comUSD 2.4m0.0%
12Persistent Asset Partners10 funds on PPLI.comUSD 1.9m0.6%
13Greenland Capital Management1 fund on PPLI.comUSD 961,0000.1%
14Two Sigma Investments35 funds on PPLI.comUSD 924,0000.0%
15Engineers Gate Manager1 fund on PPLI.comUSD 907,0000.0%
16D. E. Shaw & Co.15 funds on PPLI.comUSD 590,0000.0%
17Squarepoint Ops7 funds on PPLI.comUSD 340,0000.0%
18Jain Global1 fund on PPLI.comUSD 313,0000.0%
19Marshall Wace LLP84 funds on PPLI.comUSD 284,0000.0%
20Rangeley Capital6 funds on PPLI.comUSD 279,0000.3%
21Graham Capital Management18 funds on PPLI.comUSD 160,0000.0%
22Prelude Capital Management9 funds on PPLI.comUSD 147,0000.0%
23The Quarry1 fund on PPLI.comUSD 3590.0%
Next: where it matters most
Where it matters most

For Acuta Capital Partners it is 4.7% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Acuta Capital PartnersUSD 6.8m4.7%
2Ra Capital ManagementUSD 67m0.6%
3Persistent Asset PartnersUSD 1.9m0.6%
4Armistice CapitalUSD 27m0.3%
5Rangeley CapitalUSD 279,0000.3%
6Burkehill Global ManagementUSD 3.7m0.1%
7Greenland Capital ManagementUSD 961,0000.1%
8Arrowmark Colorado HoldingsUSD 2.7m0.1%
9RTW InvestmentsUSD 6.3m0.1%
10Adage Capital ManagementUSD 30m0.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds 4D Molecular Therapeutics, Inc.

What is the ticker symbol of 4D Molecular Therapeutics, Inc.?

4D Molecular Therapeutics, Inc. trades under the symbol FDMT on the Nasdaq. Its CUSIP, the code used on Form 13F, is 35104E100.

Which hedge funds own 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT)?

23 of the 720 hedge fund managers PPLI.com tracks reported 4D Molecular Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Ra Capital Management (USD 67m), Adage Capital Management (USD 30m), Armistice Capital (USD 27m), Citadel Advisors (USD 9.1m) and Renaissance Technologies (USD 8.2m).

How many hedge funds hold 4D Molecular Therapeutics, Inc.?

23 managers in our coverage reported it, and between them they run 338 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on 4D Molecular Therapeutics, Inc.?

Acuta Capital Partners, where the position was 4.7% of the reported 13F book at 30 June 2026.

Does this show who is short 4D Molecular Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with 4D Molecular Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.